Skip to main content

Table 2 Mean changes from baseline in components of the bishop score at 24 h

From: Recombinant human relaxin versus placebo for cervical ripening: a double-blind randomised trial in pregnant women scheduled for induction of labour

 

Mean ± SD

Pooled MTDa

n = 26

Pooled Placeboa

n = 23

Cervical Dilatation (cm)

0.63 ± 0.81

1.35 ± 1.21

Effacement (%)

0.43 ± 0.59

0.65 ± 0.75

Station

0.50 ± 1.45

0.44 ± 0.71

Consistency

0.83 ± 0.78

0.92 ± 0.63

Position of Cervix

0.83 ± 0.83

1.19 ± 0.69

  1. Mean changes from baseline in the individual components of the Bishop score at 24 h were calculated post-hoc in all patients receiving 24 h of study drug with Bishop scores available at baseline and 24 h
  2. aPooled Maximum Tolerated Dose (MTD) group includes subjects who were administered the 75 μg/kg/day dose in Parts A and B of the study. Pooled placebo group includes subjects who received placebo in Parts A and B
Back to article page

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us